Cargando…
Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients
Autores principales: | Tang, Zengwei, Yang, Yuan, Chen, Wen, Li, Enliang, Liang, Tingbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749334/ https://www.ncbi.nlm.nih.gov/pubmed/36514057 http://dx.doi.org/10.1186/s12967-022-03766-0 |
Ejemplares similares
-
Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2022) -
Correction: Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2023) -
Correction to “MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation”
por: Zhang, Zhen, et al.
Publicado: (2022) -
NUP37, a positive regulator of YAP/TEAD signaling, promotes the progression of hepatocellular carcinoma
por: Luo, Xiaoling, et al.
Publicado: (2017) -
Correction: Evaluation of MCM-2 Expression in TMA Cervical Specimens
por: Nicol, Alcina F., et al.
Publicado: (2012)